Table III.
Number of putative NF-AT, NF-κ, and GRE binding sites within proximal 2000 bp of the promoter region and the first intron, and the effect of FK506 and DEX
No. of Putative Binding Sites |
Effect on FcεRI Signalb |
|||||
---|---|---|---|---|---|---|
Gene Name | Ref. Seq.a | NF-ATc | NF-κBc | GREd | FK506 | DEX |
CCL2 | NM_002982 | 9 (2) | 4 (2) | 4 | ↑ | ↓ |
CCL7 | NM_006273 | 8 (3) | 3 (1) | 2 | ↑ | ↓ |
CXCL3 | NM_002090 | 7 (4) | 2 (0) | 0 | ↑ | ↓ |
CXCL8 | NM_000584 | 5 (1) | 2 (1) | 3 | ↑ | ↓ |
CCL1 | NM_002981 | 3 (1) | 5 (1) | 7 | ↓ | No effect |
CCL3 | NM_002983 | 8 (2) | 0 (0) | 2 | ↓ | ↑ |
CCL4 | NM_002984 | 7 (0) | 6 (3) | 4 | ↓ | ↑ |
CCL18 | NM_002988 | 6 (3) | 7 (1) | 23 | ↓ | ↑ |
GenBank accession number of the reference sequences (www.ncbi.nlm.nih.gov/Genbank/index.html).
Effect of the drugs on the chemokine mRNA expression after stimulation via FcεRI.
Number of putative NF-AT and NF-κB binding sites within proximal 2000 bp (and within 500 bp) of the promoter region is shown.
Number of putative GRE binding sites in the first intron of the genes is shown.